University of North Carolina-Chapel Hill Division of Hematology

Slides:



Advertisements
Similar presentations
Basic coagulation techniques and Quality control issues
Advertisements

1. What is the sequence of the intrinsic pathway of coagulation?
University of North Carolina-Chapel Hill Division of Hematology
Coagulation Bruno Sopko.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Basic Principles of Hemostasis
Bleeding time,clotting time, PT, and PTT
Blood coagulation involves a biological amplification system in which relatively few initiation substances sequentially activate by proteolysis a cascade.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
MLAB 1227: C OAGULATION K ERI B ROPHY - M ARTINEZ Secondary Hemostasis Part Three.
Damaged Blood Vessels. On vessel injury
Interactive Session on Clotting Profile Dr P T R Makuloluwa MBBS (Col), MD (Anaesthesiology), FRCA (Lond)
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Coagulation Cascade Ahmad Shihada Silmi Msc,FIBMS IUG Faculty of Science Medical Technology Dept.
Blood coagulation and fibrinolysis Professor Asim K. Duttaroy University of Oslo.
Hemostasis and Blood Coagulation
MLAB Coagulation Keri Brophy-Martinez
Roman Numerals. The Numbers I-1 II-2 III-3 IV-4 V-5 VI-6 VII-7 VIII-8 IX-9 X-10 C-100 D-500 M-1000.
General Approach of Haemostasis
Secondary Hemostasis Part One MLAB Coagulation Keri Brophy-Martinez.
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
MIXING STUDIES General Approach of Haemostasis
Coagulation Concepts A review of hemostasis Answers are in the notes pages.
Coagulation Mechanisms
Hemostasis and blood coagulation Lecture by Dr Sandeep :30-10:30 am.
Dr. S. Parthasarathy MD DA DNB PhD (physio) Mahatma Gandhi medical college and research institute, puducherry – India Prothrombin time.
APTT. Causes of prolonged aPTTs: 1.Spurious (common to many Coag tests): – dilution (saline, Tx), underfilled specimen, clotted, prolonged tourniquet.
Investigation of Haemostasis MS. c. program Lab-9.
Activated Partial Thromboplastin Time (aPTT)
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
Laboratory Testing in Coagulation Coagulation Keri Brophy-Martinez.
Factor Assays Robert Gosselin MT (ASCP), CLS.
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
University of North Carolina-Chapel Hill Division of Hematology
Chapter 23. Bleeding disorders associated with coagulopathy
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
HEMOSTASIS A.C.KAROBIA. HEMOSTASIS-definition Arrest of bleeding by: -Normal vasoconstriction -Abnormal obstruction -Coagulation or surgical means.
Blood coagulation. Blood coagulation Blood coagulation Conversion of fluid state of blood into semisolid state by activation and interaction of pro-coagulants.
MLAB Coagulation Keri Brophy-Martinez
Secondary Haemostasis
Pre-analytical factors that can affect coag test results
Jonny Byrnes MD CICU Attending
Activated Partial Thromboplastin Time (aPTT)
These factors prevent blood clotting - in normal state.
General Approach in Investigation of Hemostasis
Recent advances- Novoseven
General Approach of Haemostasis
General Principles of Hemostasis Kristine Krafts, M.D.
General Approach in Investigation of Hemostasis
Hypercoagulable States
What is a Blood Clot? 9/18/2018 MEDC 604 Anti-coagulants.
HEMOSTASIS BY: SATHISH RAJAMANI. ASSOCIATE PROFESSOR.
Hemodynamic disorders (1 of 3)
and anti-thrombotic pharmocology Tom Williams
Coagulation and Anti-coagulation
Coagulation Cascade of the Newborn
Anti-Coagulants Physical Process of Clotting
Steps in clotting mechanism
Activated Partial Thromboplastin Time (aPTT)
How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults  Arif H. Kamal, MD, Ayalew.
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Thrombin During Cardiopulmonary Bypass
General Principles of Hemostasis Kristine Krafts, M.D.
Anticoagulant Reversal
Principles of Coagulation Screening II
Hemostasis and Coagulation
Presentation transcript:

University of North Carolina-Chapel Hill Division of Hematology Coagulation Made Easy Alice Ma, M.D. University of North Carolina-Chapel Hill Division of Hematology

Coagulation Made Easy The PTT Pathway The PT Pathway Rather than thinking about the intrinsic and the extrinsic pathways, think about the PTT and the PT pathways.

X Coagulation Made Easy The PTT Pathway The PT Pathway The PT and the PTT pathway meet at Factor X, because “X” marks the spot.

X Coagulation Made Easy V The PTT Pathway The PT Pathway Factor V is a cofactor for Factor X, and you can remember this because V fits into the notch of the X.

X Coagulation Made Easy Prothrombin Thrombin The PTT Pathway The PT Pathway V X Prothrombin Thrombin Factor Xa converts prothrombin (Factor II) into thrombin, the most important enzyme on the planet.

X Coagulation Made Easy Prothrombin Thrombin Fibrinogen Fibrin The PTT Pathway The PT Pathway V X Thrombin, among other things, converts the soluble molecule fibrinogen into a solid fibrin clot. Prothrombin Thrombin Fibrinogen Fibrin

The Common Pathway = Small Bills V + X II = prothrombin I = fibrinogen You can remember the factors in the common pathway by remembering the bills in your wallet smaller than a $20. Don’t forget the $2 bill!

Coagulation Made Easy: The PT The PT Pathway PT has one less letter than PTT, and PT values are shorter than PTT values, because the pathway is shorter. It means that the PT pathway is also shorter. This means that there’s fewer steps to remember, and this is lucky, so the lucky PT pathway uses lucky Factor 7 to activate Factor X. 7 V X Prothrombin Thrombin Fibrinogen Fibrin

Coagulation Made Easy: The aPTT The PTT Pathway XII The PTT pathway has all those hideous roman numerals. . . How are we going to remember them? Hmmmmm. . . XI IX V X VIII Prothrombin Thrombin Fibrinogen Fibrin

Coagulation Made Easy: The aPTT The PTT Pathway T Well, just remember that the PTT is a basic TENET of hematology. TENET stands for. . . E N E V X T Prothrombin Thrombin Fibrinogen Fibrin

Coagulation Made Easy: The aPTT The PTT Pathway Twelve Eleven Nine Eight V X Ten Prothrombin Thrombin Fibrinogen Fibrin

Coagulation Made Easy: PT and PTT Both Prolonged The PTT Pathway The PT Pathway V X These factors are in the common pathway. Prothrombin (II) Fibrinogen

Coagulation Made Easy: Only PT Prolonged 7 Deficiency of Factor VII will prolong the PT but not the PTT.

Coagulation Made Easy: Only PTT Prolonged Deficiencies of Factors 12, 11, 9, and 8 will prolong the PTT and not the PT. Remember that Factor 10 is in the common pathway, and affects BOTH the PT and the PTT. Twelve Eleven Nine Eight Ten

What Matters Clinically XII XI Deficiencies of Factor XI, IX, VIII, VII. X, V, prothrombin, and fibrinogen are clinically significant. Inhibitors of these factors are clinically significant for bleeding. Deficiency of Factor XII, and the presence of the lupus anticoagulant are not. IX VIII VII X V Thrombin Fibrinogen Fibrin

Coagulation Made Easy: The Mixing Study Useful to differentiate etiologies of prolonged clotting in a coagulation assay. Patient’s plasma is mixed 50/50 with normal plasma. Coagulation assay is repeated. If “substantial” correction is noted after mix, suspect clotting factor deficiency, because you replaced deficient factors in the patient plasma with normal factors from the normal plasma. If no or not full correction is seen, suspect an inhibitor, because you added the inhibitor (think of this as an anticoagulant) in the patient plasma which inhibits clotting in the normal plasma.